Marc Lang
Signal active
Advisor
Contact Information
Social
Primary Organization
Blueprint Medicines
Founded
2011
Employees
501-1000
Industry
Biotechnology, Health Care, Medical, Bioinformatics
Bio
Dr. Marc Lang, Head Medicinal Chemistry, has more than 30 years of experience in medicinal chemistry, of which some 20 years in Oncology and Immunology. He has contributed to three multi-billion Novartis compounds on market (Femara®, Reyataz® and Tasigna®), and five promising compounds in clinical trials. Until October 2012, he was Head of Medicinal Chemistry for Oncology research programs at Novartis Pharma AG.
Dr. Lang holds a Ph.D. in Chemistry from the University of Strasbourg and was a postdoctoral fellow at the Woodward Research Institute in Basel, Switzerland
Location
Basel, Basel-Stadt, Switzerland, Europe
Jobs history
0
N/A
Educations
1
University of Strasbourg
Chemistry
Profile Resume
Marc Lang is the Advisor at Blueprint Medicines, based in Switzerland, Europe. With a background in Biotechnology, Marc Lang has a rich history of leadership and innovation.Marc Lang studied Ph.D. Chemistry at University of Strasbourg. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.